📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: miDiagnostics

1.1 - Company Overview

miDiagnostics Logo

miDiagnostics

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of next-generation point-of-care diagnostic tests and a silicon nanofluidic platform. Offers disposable tests using drops of blood to detect cells, proteins, nucleic acids and small molecules. Products include a <20 min COVID-19 PCR, a <20 min vaginitis test detecting bacterial vaginosis, vulvovaginal candidiasis and trichomonas vaginalis, a <30 min HSV-1&2 CSF test, and the nanoFluidic Processor (nFP).

Products and services

  • NanoFluidic Processor (nFP): miDiagnostics engineers a silicon-based nanofluidic chip that manipulates fluids at the nanoscale to enable fast, precise detection of cells, proteins, nucleic acids, and small molecules
  • COVID-19 PCR Test: miDiagnostics produces a PCR-based rapid test that uses a silicon chip to accurately detect SARS-CoV-2 and delivers results in less than 20 minutes
  • Vaginitis Test: miDiagnostics architects a point-of-care assay that diagnoses vaginitis by detecting bacterial vaginosis, vulvovaginal candidiasis, and trichomonas vaginalis with results in less than 20 minutes

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to miDiagnostics

Inkron Logo

Inkron

HQ: Finland Website
  • Description: Provider of dielectric and conductive inks and materials for optics and electronics, including high (1.1-2.0) and low (1.1-1.4) refractive index materials for AR/XR waveguides, optical diffusers, anti-reflective coatings, claddings, and adhesive layers; UV-curable encapsulants and thermally conductive adhesives for LED and sensor opto-packaging; plus NIL prototyping and tailored R&D services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inkron company profile →
Vorbeck Materials Logo

Vorbeck Materials

HQ: United States Website
  • Description: Provider of graphene materials (Vor-x) for industrial and energy applications; ultra-flexible, robust conductive inks and coatings (Vor-ink) for printed electronics; high-performance graphene-enabled electronic components; and custom technology solutions for municipalities, states, US Special Operations Command, and front-line troops, focusing on high-bandwidth communication and situational awareness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vorbeck Materials company profile →
SiSaf Logo

SiSaf

HQ: United Kingdom Website
  • Description: Provider of RNA delivery and therapeutics leveraging proprietary Bio-Courier, a hybrid organic–inorganic platform using bioabsorbable silicon and silicon stabilized hybrid lipid nanoparticles (sshLNP). Pipeline includes siRNA/miRNA therapies for Osteopetrosis Type II (SIS-101-ADO), Achondroplasia (SIS-102-ACH), pancreatic cancer (SIS-401-PACA), targeting genes correlating with cancer progression and mortality (SIS-402-SBC), and Type II Corneal Dystrophy (SIS-201-CD).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SiSaf company profile →
InnoMedica Logo

InnoMedica

HQ: Switzerland Website
  • Description: Provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InnoMedica company profile →
Capres Logo

Capres

HQ: Australia Website
  • Description: Provider of micro- and nano-scale electrical metrology products and instruments, including M4PP and M12PP microscopic probes, microRSP-A300, microRSP-M300, microRSP-M200, microHALL-A300, microHALL-M300, and CIPTech-M300 and CIPTech-M200.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Capres company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for miDiagnostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to miDiagnostics

2.2 - Growth funds investing in similar companies to miDiagnostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for miDiagnostics

4.2 - Public trading comparable groups for miDiagnostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to miDiagnostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About miDiagnostics

What does miDiagnostics do?

miDiagnostics is a provider of next-generation point-of-care diagnostic tests and a silicon nanofluidic platform. Offers disposable tests using drops of blood to detect cells, proteins, nucleic acids and small molecules. Products include a <20 min COVID-19 PCR, a <20 min vaginitis test detecting bacterial vaginosis, vulvovaginal candidiasis and trichomonas vaginalis, a <30 min HSV-1&2 CSF test, and the nanoFluidic Processor (nFP).

Who are miDiagnostics's competitors?

miDiagnostics's competitors and similar companies include Inkron, Vorbeck Materials, SiSaf, InnoMedica, and Capres.

Where is miDiagnostics headquartered?

miDiagnostics is headquartered in Belgium.

How many employees does miDiagnostics have?

miDiagnostics has 1,000 employees 🔒.

When was miDiagnostics founded?

miDiagnostics was founded in 2010 🔒.

What sector and industry vertical is miDiagnostics in?

miDiagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for miDiagnostics

Who are the top strategic acquirers in miDiagnostics's sector and industry

Top strategic M&A buyers and acquirers in miDiagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for miDiagnostics?

Top strategic M&A buyers groups and sectors for miDiagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in miDiagnostics's sector and industry vertical

Which are the top PE firms investing in miDiagnostics's sector and industry vertical?

Top PE firms investing in miDiagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in miDiagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in miDiagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in miDiagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to miDiagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in miDiagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for miDiagnostics?

The key public trading comparables and valuation benchmarks for miDiagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for miDiagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for miDiagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in miDiagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for miDiagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in miDiagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in miDiagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for miDiagnostics